CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 45 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $27,000 | 0.0% | 3,851 | 0.0% | 0.00% | – |
| Q2 2017 | $27,000 | 0.0% | 3,851 | 0.0% | 0.00% | – |
| Q1 2017 | $27,000 | +28.6% | 3,851 | 0.0% | 0.00% | – |
| Q4 2016 | $21,000 | +10.5% | 3,851 | 0.0% | 0.00% | – |
| Q3 2016 | $19,000 | +11.8% | 3,851 | 0.0% | 0.00% | – |
| Q2 2016 | $17,000 | 0.0% | 3,851 | 0.0% | 0.00% | – |
| Q1 2016 | $17,000 | -15.0% | 3,851 | 0.0% | 0.00% | – |
| Q4 2015 | $20,000 | -9.1% | 3,851 | 0.0% | 0.00% | – |
| Q3 2015 | $22,000 | -21.4% | 3,851 | 0.0% | 0.00% | – |
| Q2 2015 | $28,000 | +7.7% | 3,851 | 0.0% | 0.00% | – |
| Q1 2015 | $26,000 | +13.0% | 3,851 | 0.0% | 0.00% | – |
| Q4 2014 | $23,000 | +21.1% | 3,851 | 0.0% | 0.00% | – |
| Q3 2014 | $19,000 | +11.8% | 3,851 | 0.0% | 0.00% | – |
| Q2 2014 | $17,000 | 0.0% | 3,851 | 0.0% | 0.00% | – |
| Q1 2014 | $17,000 | -15.0% | 3,851 | 0.0% | 0.00% | – |
| Q4 2013 | $20,000 | +17.6% | 3,851 | 0.0% | 0.00% | – |
| Q3 2013 | $17,000 | -63.0% | 3,851 | -57.6% | 0.00% | – |
| Q2 2013 | $46,000 | – | 9,087 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 739,917 | $5,135,000 | 2.89% |
| JW Asset Management, LLC | 263,881 | $1,830,000 | 0.38% |
| BARD ASSOCIATES INC | 442,825 | $3,075,000 | 0.29% |
| Ariel Investments | 1,393,125 | $9,668,000 | 0.11% |
| TFS CAPITAL LLC | 11,499 | $80,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 293,700 | $2,038,000 | 0.02% |
| DELTA ASSET MANAGEMENT LLC/TN | 12,000 | $83,000 | 0.01% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 10,945 | $76,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 52,767 | $366,000 | 0.01% |
| Spark Investment Management LLC | 22,600 | $156,000 | 0.01% |